BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9070338)

  • 1. Comparison of accelerated hyperfractionated radiotherapy and conventional radiotherapy for supratentorial malignant glioma.
    Shibamoto Y; Nishimura Y; Tsutsui K; Sasai K; Takahashi M; Abe M
    Jpn J Clin Oncol; 1997 Feb; 27(1):31-6. PubMed ID: 9070338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma--possible advantage observed at 72.0 Gy in 1.2 Gy B.I.D. fractions: report of the Radiation Therapy Oncology Group Protocol 8302.
    Nelson DF; Curran WJ; Scott C; Nelson JS; Weinstein AS; Ahmad K; Constine LS; Murray K; Powlis WD; Mohiuddin M
    Int J Radiat Oncol Biol Phys; 1993 Jan; 25(2):193-207. PubMed ID: 8380567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase II study of radiotherapy after hyperbaric oxygenation combined with interferon-beta and nimustine hydrochloride to treat supratentorial malignant gliomas.
    Beppu T; Kamada K; Nakamura R; Oikawa H; Takeda M; Fukuda T; Arai H; Ogasawara K; Ogawa A
    J Neurooncol; 2003 Jan; 61(2):161-70. PubMed ID: 12622455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma.
    Weller M; Müller B; Koch R; Bamberg M; Krauseneck P;
    J Clin Oncol; 2003 Sep; 21(17):3276-84. PubMed ID: 12947063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of a randomized trial comparing BCNU plus radiotherapy, streptozotocin plus radiotherapy, BCNU plus hyperfractionated radiotherapy, and BCNU following misonidazole plus radiotherapy in the postoperative treatment of malignant glioma.
    Deutsch M; Green SB; Strike TA; Burger PC; Robertson JT; Selker RG; Shapiro WR; Mealey J; Ransohoff J; Paoletti P
    Int J Radiat Oncol Biol Phys; 1989 Jun; 16(6):1389-96. PubMed ID: 2542193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperfractionated radiotherapy and multi-agent chemotherapy (procarbazine, ACNU and vincristine) for high-grade gliomas: a prospective study.
    Ogawa K; Yoshii Y; Toita T; Saito A; Kakinohana Y; Iraha S; Sugimoto K; Tsuchida Y; Tamaki W; Adachi G; Hyodo A; Murayama S
    Anticancer Res; 2006; 26(3B):2457-62. PubMed ID: 16821632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiotherapy in supratentorial gliomas. A study of 821 cases.
    Heesters M; Molenaar W; Go GK
    Strahlenther Onkol; 2003 Sep; 179(9):606-14. PubMed ID: 14628126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome?
    Nieder C; Andratschke N; Wiedenmann N; Busch R; Grosu AL; Molls M
    Strahlenther Onkol; 2004 Jul; 180(7):401-7. PubMed ID: 15241527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated hyperfractionated radiotherapy in supratentorial malignant astrocytomas.
    Genc M; Zorlu AF; Atahan IL
    Radiother Oncol; 2000 Aug; 56(2):233-8. PubMed ID: 10927143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Accelerated hyperfractionation in the treatment of malignant glioma].
    Sugawara T; Nakazawa M; Mizutani Y; Hyodoh H
    Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Mar; 54(4):278-85. PubMed ID: 8177703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human interferon beta, nimustine hydrochloride, and radiation therapy in the treatment of newly diagnosed malignant astrocytomas.
    Watanabe T; Katayama Y; Yoshino A; Fukaya C; Yamamoto T
    J Neurooncol; 2005 Mar; 72(1):57-62. PubMed ID: 15803376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose conformal radiotherapy for supratentorial malignant glioma: a historical comparison.
    Tanaka M; Ino Y; Nakagawa K; Tago M; Todo T
    Lancet Oncol; 2005 Dec; 6(12):953-60. PubMed ID: 16321763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accelerated radiotherapy with concomitant ACNU/Ara-C for the treatment of malignant glioma.
    Anders K; Grabenbauer GG; Schuchardt U; Fahlbusch R; Fietkau R; Sauer R; Krauseneck P
    J Neurooncol; 2000 May; 48(1):63-73. PubMed ID: 11026699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperfractionated radiation therapy for incompletely resected supratentorial low-grade glioma. A phase II study.
    Jeremic B; Shibamoto Y; Grujicic D; Milicic B; Stojanovic M; Nikolic N; Dagovic A
    Radiother Oncol; 1998 Oct; 49(1):49-54. PubMed ID: 9886697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Radiation therapy of adult cerebral glioblastoma:].
    Hayakawa K; Arai M; Niibe H; Tamura M
    Gan No Rinsho; 1989 Sep; 35(11):1247-54. PubMed ID: 2810773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperfractionated radiation therapy for incompletely resected supratentorial low-grade glioma: a 10-year update of a phase II study.
    Jeremic B; Milicic B; Grujicic D; Samardzic M; Antunovic V; Dagovic A; Aleksandrovic J; Stojanovic M
    Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):465-71. PubMed ID: 12957258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I/II trial of hyperfractionated concomitant boost proton radiotherapy for supratentorial glioblastoma multiforme.
    Mizumoto M; Tsuboi K; Igaki H; Yamamoto T; Takano S; Oshiro Y; Hayashi Y; Hashii H; Kanemoto A; Nakayama H; Sugahara S; Sakurai H; Matsumura A; Tokuuye K
    Int J Radiat Oncol Biol Phys; 2010 May; 77(1):98-105. PubMed ID: 19695794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiotherapy combined with nimustine hydrochloride and etoposide for malignant gliomas: results of a pilot study.
    Tanaka M; Shibui S; Nomura K; Nakanishi Y
    Jpn J Clin Oncol; 2001 Jun; 31(6):246-50. PubMed ID: 11463801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of ACNU alone and combined with tegafur as additions to radiotherapy of the treatment of malignant gliomas--a cooperative clinical trial].
    Ushio Y; Abe H; Suzuki J; Tanaka R; Kitamura K; Miwa T; Matsutani M; Takeuchi K; Takakura K; Nomura K
    No To Shinkei; 1985 Oct; 37(10):999-1006. PubMed ID: 3000412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered and conventional fractionated radiotherapy in locoregional control and survival of patients with squamous cell carcinoma of the larynx, oropharynx, and hypopharynx.
    Krstevska V; Crvenkova S
    Croat Med J; 2006 Feb; 47(1):42-52. PubMed ID: 16489696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.